Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



TOMSICEK MICHAEL JOHN Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $3.86, valued at $115.8k
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/11/2022 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $6.07, valued at $182.1k
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2021 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 30,000 options to buy @ $5.54, valued at $166.2k
03/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2020 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Sold 2,800 shares @ $91.39, valued at $255.9k
Sold 6,400 shares @ $92.23, valued at $590.3k
Sold 2,800 shares @ $93.18, valued at $260.9k
Exercised 12,000 options to buy @ $17.75, valued at $213k
08/05/2020 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Exercised 12,000 shares @ $17.75, valued at $213k
Sold 6,552 shares @ $86.2528, valued at $565.1k
Sold 5,448 shares @ $87.333, valued at $475.8k
Exercised 12,000 options to buy @ $17.75, valued at $213k
06/08/2020 4 TOMSICEK MICHAEL JOHN (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.
Txns: Granted 15,000 options to buy @ $3.74, valued at $56.1k
03/12/2020 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 35,000 options to buy @ $44.67, valued at $1.6M
Granted 8,500 restricted stock units @ $0
12/05/2019 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 20,000 restricted stock units @ $0
03/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2018 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 20,760 options to buy @ $59.31, valued at $1.2M
03/09/2018 4 TOMSICEK MICHAEL JOHN (CFO) has filed a Form 4 on CRISPR Therapeutics AG
Txns: Granted 25,000 options to buy @ $51.49, valued at $1.3M
11/14/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/02/2013 4 TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Acquired 74 shares @ $63.55, valued at $4.7k
09/05/2013 4 TOMSICEK MICHAEL JOHN (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Sold 400 shares @ $64.08, valued at $25.6k
04/16/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy